• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Akebia Therapeutics (NQ: AKBA )

    1.350 -0.010 (-0.74%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,881,964
    Open 1.350
    Bid (Size) 1.350 (65)
    Ask (Size) 1.380 (50)
    Prev. Close 1.360
    Today's Range 1.300 - 1.370
    52wk Range 0.7801 - 2.480
    Shares Outstanding 174,537,458
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024
    AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    +6.30%
    +6.30%
    1 Month
    +48.35%
    +48.35%
    3 Month
    -0.74%
    -0.74%
    6 Month
    -2.88%
    -2.88%
    1 Year
    +10.66%
    +10.66%

    More News

    Read More
    Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
    Via MarketBeat
    Exposures Product Safety
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Recap: Akebia Therapeutics Q4 Earnings
    Via Benzinga
    Earnings Preview For Akebia Therapeutics
    Via Benzinga
    Earnings Outlook For Akebia Therapeutics
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Akebia Therapeutics Inc. (NASDAQ: AKBA) is One of Thursday Morning’s Most Active Stocks
    Via Investor Brand Network
    FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
    Via Benzinga
    Exposures Product Safety
    Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Earnings Scheduled For March 14, 2024
    Via Benzinga
    Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
    Via Benzinga
    Earnings Scheduled For August 25, 2023
    Via Benzinga
    Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.